Cargando…

The effects of probiotics administration on the gut microbiome in adolescents with anorexia nervosa—A study protocol for a longitudinal, double‐blind, randomized, placebo‐controlled trial

OBJECTIVE: Knowledge on gut–brain interaction might help to develop new therapies for patients with anorexia nervosa (AN), as severe starvation‐induced changes of the microbiome (MI) do not normalise with weight gain. We examine the effects of probiotics supplementation on the gut MI in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gröbner, Eva‐Maria, Zeiler, Michael, Fischmeister, Florian Ph. S., Kollndorfer, Kathrin, Schmelz, Sonja, Schneider, Andrea, Haid‐Stecher, Nina, Sevecke, Kathrin, Wagner, Gudrun, Keller, Lara, Adan, Roger, Danner, Unna, van Elburg, Annemarie, van der Vijgh, Benny, Kooij, Karlijn Liselotte, Fetissov, Serguei, Andreani, Nadia A., Baines, John F., Dempfle, Astrid, Seitz, Jochen, Herpertz‐Dahlmann, Beate, Karwautz, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300207/
https://www.ncbi.nlm.nih.gov/pubmed/34851002
http://dx.doi.org/10.1002/erv.2876
Descripción
Sumario:OBJECTIVE: Knowledge on gut–brain interaction might help to develop new therapies for patients with anorexia nervosa (AN), as severe starvation‐induced changes of the microbiome (MI) do not normalise with weight gain. We examine the effects of probiotics supplementation on the gut MI in patients with AN. METHOD: This is a study protocol for a two‐centre double‐blind randomized‐controlled trial comparing the clinical efficacy of multistrain probiotic administration in addition to treatment‐as‐usual compared to placebo in 60 patients with AN (13–19 years). Moreover, 60 sex‐ and age‐matched healthy controls are included in order to record development‐related changes. Assessments are conducted at baseline, discharge, 6 and 12 months after baseline. Assessments include measures of body mass index, psychopathology (including eating‐disorder‐related psychopathology, depression and anxiety), neuropsychological measures, serum and stool analyses. We hypothesise that probiotic administration will have positive effects on the gut microbiota and the treatment of AN by improvement of weight gain, gastrointestinal complaints and psychopathology, and reduction of inflammatory processes compared to placebo. CONCLUSIONS: If probiotics could help to normalise the MI composition, reduce inflammation and gastrointestinal discomfort and increase body weight, its administration would be a readily applicable additional component of multi‐modal AN treatment.